2021
DOI: 10.1016/j.ctrv.2021.102263
|View full text |Cite
|
Sign up to set email alerts
|

Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 105 publications
(175 reference statements)
0
21
0
Order By: Relevance
“…Current implementations of the omics results are mainly focused on treatment outcome prediction and risk of recurrence rather than on direct personalisation of individual patient therapy [56]. It is expected that future developments in the discussed omics fields will influence the treatment of the individual patient from first contact with the healthcare system by allowing clinicians to deploy a truly individualised treatment based on radiomic analysis of diagnostic imaging, on detailed dosiomic analysis to target the tumour volume with utmost precision, alleviating side effects on healthy tissues, and on pharmacogenetic tests that enable the choice of the most effective drug family for the individual patient.…”
Section: Discussionmentioning
confidence: 99%
“…Current implementations of the omics results are mainly focused on treatment outcome prediction and risk of recurrence rather than on direct personalisation of individual patient therapy [56]. It is expected that future developments in the discussed omics fields will influence the treatment of the individual patient from first contact with the healthcare system by allowing clinicians to deploy a truly individualised treatment based on radiomic analysis of diagnostic imaging, on detailed dosiomic analysis to target the tumour volume with utmost precision, alleviating side effects on healthy tissues, and on pharmacogenetic tests that enable the choice of the most effective drug family for the individual patient.…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge, the xerostomia predictive models proposed in the literature are designed for head and neck tumors which include several locations anatomical sites of the primary tumor. There is a lack of models tailored for patients with OPC (15,16). Compared to treatment in other areas of the head and neck, the oropharynx represents the most frequently treated site for which the definition of a plan that preserves the functionality of the parotid is more complex (17,18).…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the average RGB color for each image was calculated; then, the color consistency was calculated by adjusting the scale for each image [ 21 ]. Finally, artifacts were removed, image contrast increased, and the edges of regions of interest were revealed by Gaussian and Laplacian filters [ 22 ]. Next, the images were passed over a Gaussian noise filter by removing high-frequency data and passing (retaining) the low-frequency data.…”
Section: Methodsmentioning
confidence: 99%